Zebrafish as a Versatile Screening Model for Neurological Diseases: Insights Into Biology, Drug Delivery and Therapeutic Discovery
Journal of Biochemical and Molecular Toxicology · 2026
DOI: 10.1002/jbt.70750 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Sambhaji Vyavahare und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jaihind College of Pharmacy, Vadgaon Sahani, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Zebrafish, Disease Models, Animal, Nervous System Diseases, Drug Discovery. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 297 Literaturangaben.
Abstract (Originalsprache)
Neurological diseases such as Alzheimer's disease, Parkinson's disease, anxiety, depression, and Huntington's disease pose significant challenges due to their complex pathophysiology and limited treatment options. Traditional mammalian models, although widely used, often face limitations in cost, ethical concerns, and scalability. Zebrafish have become an excellent animal model for neurological research in recent years because of their remarkable genetic similarity to humans, well‐preserved neurotransmitter systems, and readiness for high‐throughput behavioural and pharmacological investigations. This review provides a comprehensive overview of the role of zebrafish in modelling neurological disorders and drug discovery. It first highlights the anatomical and neurochemical features of the zebrafish nervous system, followed by various drug administration strategies, including bath immersion, microinjection, oral administration and advanced delivery systems such as nanoparticles, hydrogels, and genetic manipulation techniques. Furthermore, the review explores zebrafish models for major neurological and psychiatric disorders, emphasizing their applications in drug screening, evaluation of neuroprotective compounds and repurposing therapeutics. Additionally, the future perspectives address innovations in genetic engineering, targeted delivery systems, and the integration of omics technologies for translational neuroscience research. Despite inherent limitations and differences from mammalian systems, zebrafish offers unique advantages as an in vivo screening platform.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jaihind College of Pharmacy, Vadgaon Sahani, Pune, Maharashtra, India.
- Office of Research Administration, Chiang Mai University, Chaing Mai, Thailand.
- Faculty of Pharmacy, Chiang Mai University, Chaing Mai, Thailand.
ORCID-Profile: Sambhaji Vyavahare, Atharva Pawar, Shafiya A Sayyed, Neha Shegar, Sakshi Raykar, Rohit Doke, Sudarshan Singh
Zitieren
APA
Vyavahare, S., Pawar, A., Sayyed, S. A., Shegar, N., Raykar, S., Doke, R., & Singh, S. (2026). Zebrafish as a Versatile Screening Model for Neurological Diseases: Insights Into Biology, Drug Delivery and Therapeutic Discovery. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70750
Vancouver
Vyavahare S, Pawar A, Sayyed SA, Shegar N, Raykar S, Doke R, et al. Zebrafish as a Versatile Screening Model for Neurological Diseases: Insights Into Biology, Drug Delivery and Therapeutic Discovery. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.70750
BibTeX
@article{Vyavahare2026,
author = {Vyavahare, Sambhaji and Pawar, Atharva and Sayyed, Shafiya A and Shegar, Neha and Raykar, Sakshi and Doke, Rohit and Singh, Sudarshan},
title = {Zebrafish as a Versatile Screening Model for Neurological Diseases: Insights Into Biology, Drug Delivery and Therapeutic Discovery},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
doi = {10.1002/jbt.70750}
}
EUVIMED